Next Article in Journal
Twenty Years’ Experience in Retroperitoneal Lymph Node Dissection for Testicular Cancer in a Tertiary Referral Center
Previous Article in Journal
Polymorphisms of Antioxidant Enzymes SOD2 (rs4880) and GPX1 (rs1050450) Are Associated with Bladder Cancer Risk or Its Aggressiveness
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Medicina
Volume 59
Issue 1
10.3390/medicina59010132
medicina-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Emerging Use of Vaginal Laser to Treat Genitourinary Syndrome of Menopause for Breast Cancer Survivors: A Review

by
Nida Jugulytė
1,*,
Guoda Žukienė
2 and
Daiva Bartkevičienė
2
1
Faculty of Medicine, Vilnius University, LT-03101 Vilnius, Lithuania
2
Clinic of Obstetrics and Gynaecology, Faculty of Medicine, Institute of Clinical Medicine, Vilnius University, LT-03101 Vilnius, Lithuania
*
Author to whom correspondence should be addressed.
Medicina 2023, 59(1), 132; https://doi.org/10.3390/medicina59010132
Submission received: 16 December 2022 / Revised: 3 January 2023 / Accepted: 7 January 2023 / Published: 9 January 2023
(This article belongs to the Section Obstetrics and Gynecology)
Versions Notes

Abstract

Breast cancer treatment, such as chemotherapy and endocrine therapy, can cause earlier and more sudden menopausal symptoms. Genitourinary syndrome of menopause (GSM) is one of the most bothersome side effects of breast cancer treatment, resulting in sexual dysfunction and impaired quality of life. GSM includes genital, urinary, and sexual symptoms. However, alleviating symptoms of GSM for breast cancer survivors may be challenging due to ineffectiveness, contraindications, and low adherence to treatment. The most recent data show the feasibility and safety of vaginal laser to treat GSM for breast cancer survivors. This narrative review provides the aspects of GSM in breast cancer patients, putting the focus on the efficacy and safety of vaginal laser therapy.
Keywords: genitourinary syndrome of menopause; vulvovaginal atrophy; breast cancer survivor; vaginal laser genitourinary syndrome of menopause; vulvovaginal atrophy; breast cancer survivor; vaginal laser

Share and Cite

MDPI and ACS Style

Jugulytė, N.; Žukienė, G.; Bartkevičienė, D. Emerging Use of Vaginal Laser to Treat Genitourinary Syndrome of Menopause for Breast Cancer Survivors: A Review. Medicina 2023, 59, 132. https://doi.org/10.3390/medicina59010132

AMA Style

Jugulytė N, Žukienė G, Bartkevičienė D. Emerging Use of Vaginal Laser to Treat Genitourinary Syndrome of Menopause for Breast Cancer Survivors: A Review. Medicina. 2023; 59(1):132. https://doi.org/10.3390/medicina59010132

Chicago/Turabian Style

Jugulytė, Nida, Guoda Žukienė, and Daiva Bartkevičienė. 2023. "Emerging Use of Vaginal Laser to Treat Genitourinary Syndrome of Menopause for Breast Cancer Survivors: A Review" Medicina 59, no. 1: 132. https://doi.org/10.3390/medicina59010132

APA Style

Jugulytė, N., Žukienė, G., & Bartkevičienė, D. (2023). Emerging Use of Vaginal Laser to Treat Genitourinary Syndrome of Menopause for Breast Cancer Survivors: A Review. Medicina, 59(1), 132. https://doi.org/10.3390/medicina59010132

Article Metrics

Back to TopTop